Longevity Korsana emerges with $175m to combat neurodegenerationBy adminFebruary 22, 20260 Paragon’s latest venture targets Alzheimer’s via delivery platform designed to cross the blood-brain barrier. US biotech Korsana Biosciences has emerged…